Showing results (1-10 of 571) with videos related to
Sort By:
Pageof 58
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 21, 2005
Resistance to epidermal growth factor receptor-targeted therapyFloriana Morgillo, Ho-Young LeeExpert Opinion on Investigational Drugs|May 31, 2006
Lonafarnib in cancer therapyFloriana Morgillo, Ho-Young LeeCancer Research|October 19, 2006
Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinibFloriana Morgillo, Jong Kyu Woo, Edward S Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinibFloriana Morgillo, Woo-Young Kim, Edward S Kim, et al.Journal of the National Cancer Institute|September 8, 2005
Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancerJi-Youn Han, Seung Hyun Oh, Floriana Morgillo, et al.ESMO Open|March 12, 2020
How I treat malignant pleural mesotheliomaGiuseppe Viscardi, Raimondo Di Liello, Floriana MorgilloCancer Treatment Reviews|January 11, 2017
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEKErika Martinelli, Floriana Morgillo, Teresa Troiani, et al.Journal of Cellular Physiology|April 3, 2008
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cellsTina Cascone, Maria Pia Morelli, Floriana Morgillo, et al.Annals of Translational Medicine|May 21, 2015
Role of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agentsRaffaele Califano, Floriana Morgillo, Ramon Andrade De Mello, et al.ESMO Open|November 16, 2016
Mechanisms of resistance to EGFR-targeted drugs: lung cancerFloriana Morgillo, Carminia Maria Della Corte, Morena Fasano, et al.Pageof 58